Category: Regulations

  • NSF Grant to Fund Natural Gas Development Impacts Study

    An engineering research team at University of Colorado in Boulder will study the balance between natural gas development and its effects on ecosystems and communities. The five-year, $12 million study is funded by National Science Foundation under its Sustainability Research Network initiative. The Colorado team led by environmental engineering professor Joseph Ryan will examine social,…

  • Enrollment Begins for Mesothelioma Vaccine Clinical Trial

    Aduro BioTech Inc. in Berkeley, California enrolled the first patient in a clinical trial of a therapeutic cancer vaccine to treat malignant pleural mesothelioma. The trial will test the safety and immune response of Aduro BioTech’s CRS-207 vaccine combined with chemotherapy on patients recently diagnosed with the disease. The phase 1B trial is expect to…

  • Smartphones Found Feasible Tools for Telemedicine Images

    Researchers at the Mayo Clinic in Phoenix and clinician colleagues in Arizona found smartphones could exchange acceptable teleradiology images for stroke diagnosis under real-world conditions. The findings from this clinical trial appear online in the journal Stroke. The research, led by Mayo Clinic neurologist Bart Demaerschalk, tested the smartphone application ResolutionMD used to transmit CT…

  • Artificial Kidney Project Lands New $750,000 Funding

    The Kidney Project, an academic-corporate initiative led by University of California in San Francisco to develop an implantable device to replace failed kidneys, secured a new $750,000 grant from the John and Marcia Goldman Foundation. The funding supplements a $2.25 million grant received this summer from National Institutes of Health (NIH). The artificial kidney aims…

  • FDA Approves Colorectal Cancer Treatment

    The U.S. Food and Drug Administration approved the drug regorafenib to treat patients with metastatic colorectal cancer, where the cancer has progressed after treatment and spread to other parts of the body. Regorafenib is marketed under the brand name Stivarga by Bayer HealthCare Pharmaceuticals, in Wayne, New Jersey. Stivarga blocks several enzymes that promote cancer…

  • European Approval Granted for Breast Cancer Gene Test

    NanoString Technologies Inc. in Seattle, a developer of genetic medical diagnostics, received a CE mark noting regulatory approval in Europe for its PAM50-based gene expression test for breast cancer. The CE mark, an acronym for the French Conformité Européene, indicates a product meets safety, health, and environmental protection requirements in the 27 EU member states,…

  • Clinical Trial to Evaluate Type 2 Diabetes Treatments

    A clinical trial coordinated by George Washington University in Washington, D.C. will test the effectiveness of glucose-lowering drugs in treating type 2 diabetes. The five year, $134 million study is funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) at National Institute of Health. John Lachin, professor of biostatistics, epidemiology and…

  • Grant to Fund Study of Cyber Crime Economics, Networks

    Computer scientists at University of California in San Diego, University of California in Berkeley, and George Mason University in Fairfax, Virginia received a National Science Foundation grant to better understand the economics and network dynamics of cyber crime. The five-year, $10 million study will investigate economic motivations and social interactions among cyber criminals, as well…

  • European Approval Granted for Implanted Migraine Device

    St. Jude Medical Inc., a medical device developer in St. Paul, Minnesota, received a CE mark indicating regulatory approval in Europe for its Eon line of neurostimulators to treat chronic migraine. The CE mark, an acronym for the French Conformité Européene, indicates a product meets safety, health and environmental protection requirements in the 27 EU…

  • FDA Approves Inhaled Aerosol Asthma Maintenance Drug

    Acton Pharmaceuticals Inc. in Marlborough, Massachusetts reports the U.S. Food and Drug Administration approved its drug Aerospan, an orally inhaled corticosteroid for the prevention of asthma attacks. The FDA approval, says Acton, came in response to a supplemental new drug application, and will enable the company to launch the drug in the U.S. during the…